Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States ...

Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven research firms that are presently covering the stock, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

This prediction is currently active. With a performance of -2.54%, the BUY prediction by Jefferies_Financial_ is trending in the wrong direction. This prediction currently runs until 02.01.26. The ...

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The ...

sharewise wants to provide you with the best news and tools for Rhythm Pharmaceuticals, so we directly link to the best financial data sources.

What are the best rhythm games on PC? There are few things in life better than music, so obviously there are even fewer things in life better than music and rhythm games. Music evokes more ...

Shares of Rhythm Pharmaceuticals, Inc. (RYTM) have gained 0.3% over the past four weeks to close the last trading session at $56.52, but there could still be a solid upside left in the stock if ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

Rhythm Pharmaceuticals, Inc. (RYTM) shares soared 5.5% in the last trading session to close at $57.52. The move was backed by solid volume with far more shares changing hands than in a normal session.